Pfizer's Zoetis Surges in Trading Debut After $2.24 Billion IPO

Juan Ramon Alaix, chief executive officer of Zoetis Inc., center left, smiles after ringing the opening bell at the New York Stock Exchange (NYSE) in New York, U.S., on Friday, Feb. 1, 2013. Zoetis Inc., the animal-health company owned by Pfizer Inc., surged as much as 22 percent in its debut after raising $2.24 billion in its initial public offering, pricing the shares above the proposed price range. Photographer: Jin Lee/Bloomberg via Getty Images
Juan Ramon Alaix, chief executive officer of Zoetis Inc., center left, smiles after ringing the opening bell at the New York Stock Exchange (NYSE) in New York, U.S., on Friday, Feb. 1, 2013. Zoetis Inc., the animal-health company owned by Pfizer Inc., surged as much as 22 percent in its debut after raising $2.24 billion in its initial public offering, pricing the shares above the proposed price range. Photographer: Jin Lee/Bloomberg via Getty Images
Pfizer's Zoetis Surges in Trading Debut After $2.24 Billion IPO
PURCHASE A LICENCE
How can I use this image?
$650.00
AUD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
160478981
Collection:
Bloomberg
Date created:
01 February, 2013
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
ZOETIS SHARES